CETP and type 2 diabetes mellitus: The clinical relevance of these studies has been consolidated by the outcomes of several randomised clinical trials where increasing HDL-C levels in T2D patients with a CETP inhibitor or with an rHDL infusion is associated with improved glycaemic control.